#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic hepatitis B Pemphigoid Immune-mediated renal disorder Immunodeficiency Bladder cancer Cerebral arteriovenous malformation haemorrhagic Chronic granulomatous disease Sickle cell anaemia Enteritis Paget's disease of the vulva Cutaneous T-cell lymphoma refractory Acute lymphocytic leukaemia recurrent Malignant central nervous system neoplasm Neoplasm Hypochromic anaemia More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Life with Disease Fragile X syndrome – Basic Information Haemophilia – Life with Disease Osteosarcoma metastatic – Diagnostics Alport’s syndrome – Diagnostics Ocular melanoma – Trials in Disease Primary hyperoxaluria – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Familial amyotrophic lateral sclerosis – Treatment Prader-Willi syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iptacopan Tigecycline L-Tryptophan Paroxetine Gsk3915393 Dnth103 SGT-003 Azilsartan Medoxomil Decitabine Venetoclax Epoetin Alfa Brimonidine Tartrate Dextran 70 Varenicline Alisertib Sodium Ataluren Hydrocortisone Hemisuccinate Pamidronate Disodium Pal1-15 Acetate Dipyridamole More therapies…

    Learn about Your Condition

    Supraventricular tachycardia Alveolar proteinosis Vulvovaginal dryness Chondrocalcinosis Large cell lung cancer Retinoblastoma Adenocarcinoma gastric Turner's syndrome Neuroendocrine carcinoma Cold urticaria Inborn error of metabolism Circulatory collapse Hyperoxaluria Chronic granulomatous disease Sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of atrasentan in children aged 2 to <18 years with primary IgA nephropathy to evaluate proteinuria reduction, safety and tolerability

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Atrasentan Hydrochloride
    France Spain

  • Topical delgocitinib safety study in patients with cutaneous T‑cell lymphoma (mycosis fungoides)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma
    Denmark

  • Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Benralizumab
    Austria Belgium Denmark France Italy The Netherlands +1

  • Study of Everolimus and Mycophenolate Mofetil to Reduce Cytomegalovirus Viral Load in Solid Organ Transplant Recipients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Everolimus
    • Mycophenolate Mofetil
    France Spain

  • Effect of Verapamil Hydrochloride on Beta Cell Function in Children and Adults Aged 7‑45 with Stage 1 or Stage 2 Type 1 Diabetes (48‑Week Study)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Verapamil Hydrochloride
    France

  • Individualized beta‑lactam dosing with piperacillin (drug combination) for ICU patients with sepsis caused by gram‑negative bacteria

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Meropenem Trihydrate
    • Avibactam
    • Ceftazidime
    France
Previous Page
1 … 668 669 670 671 672 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!